Seed Round

Ottawa's Design 1st marks three decades with a record year, proving the enduring demand for complex hardware from medical implants to consumer gadgets.

GSK's subsidiary Tesaro inks a deal worth up to $285M with Alteogen to create an under-the-skin version of its cancer drug Jemperli.

Deeplumen's new tool for Google's UCP signals a massive shift to 'agentic commerce,' where AIs shop for you. But are brands ready for this new world?

Following a spin-out and $5M financing, new explorer Blue Jay Gold aims to unlock value at its Steller Project and list on the TSX Venture Exchange.

As the RWA market booms, MSV Protocol launches its Proof-of-Asset Integrity framework to solve the critical trust gap with continuous, on-chain monitoring.

Crosswalk Therapeutics secures a key grant to develop a therapy targeting the debilitating skeletal disease in Morquio A, a challenge current treatments can't solve.

American Lithium Minerals acquires a high-grade gold claim in BC's Golden Triangle while pivoting to a revolutionary but risky blockchain financing model.

The AR automation firm is launching Benji Payments, leveraging Adyen's global platform to streamline cash flow and operations for MSPs and SMBs.

Slingshot Aerospace's TALOS AI will create unpredictable, machine-speed adversaries, revolutionizing how Guardians prepare for orbital conflict.

Four startups won the UAE FoodTech Challenge, sharing $2M to scale their solutions for food production and waste reduction from the UAE to the Global South.

As Moelis & Co. prepares to report its 2025 results, investors are watching to see if the firm capitalized on a record year for dealmaking.

With a promising brain injury drug and no approved rivals, Oragenics heads to a tax-haven investor summit to secure funding for its next critical phase.

The U.S. Army partners with Velo3D, using advanced 3D printing to create mission-critical metal parts and bolster the readiness of its combat fleet.

Amid rapid industry consolidation, doctor-owned DSO PepperPointe Partnerships adds three VPs to scale its unique model and support continued expansion.

Biotech veteran Kamran Tavangar, who built a multi-billion dollar company at LabCentral, returns to lead its science strategy and shape the future of innovation.

A new partnership aims to move AI from costly experiments to real-world value in biopharma, combining specialized agents with strategic implementation.

Backed by CRISPR pioneers and $16M, a new biotech aims to make personalized gene therapies a scalable reality for millions with rare genetic disorders.

Renowned scientist Eric Hoek becomes Executive Chairman at Active Membranes, aiming to commercialize a technology that could cut water treatment costs by 50%.

Nanyang Polytechnic's new AI Nexus Lab, backed by AWS, pairs students with small businesses to solve real-world problems and close Singapore's AI gap.

Pharma giant Lilly and AI biotech BigHat are teaming up to solve a critical flaw in AI drug discovery, aiming to unlock a new generation of therapies.